These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2243448)

  • 1. Does H2-receptor antagonist alter the renal function of cyclosporine-treated kidney grafts?
    Inoue S; Sugimoto H; Nagao T; Akiyama N
    Jpn J Surg; 1990 Sep; 20(5):553-8. PubMed ID: 2243448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of famotidine, a new histamine H2-receptor antagonist, on renal function.
    Ishigami M; Sezai Y; Shimada Y; Maeda T; Yabuki S
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):687-91. PubMed ID: 2571741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
    Laskow DA; Curtis JJ; Luke RG; Julian BA; Jones P; Deierhoi MH; Barber WH; Diethelm AG
    Am J Med; 1990 May; 88(5):497-502. PubMed ID: 2337107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of nephrotoxicity by H2-antagonists in patients receiving cyclosporine.
    Lewis SM; McCloskey WW
    Ann Pharmacother; 1997 Mar; 31(3):363-5. PubMed ID: 9066946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.
    Barry JM; Shively N; Hubert B; Hefty T; Norman DJ; Bennett WM
    Transplantation; 1988 Feb; 45(2):346-8. PubMed ID: 3278427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of famotidine on renal function in patients with renal insufficiency.
    Abraham PA; Opsahl JA; Halstenson CE; Chremos AN; Matzke GR; Keane WF
    Br J Clin Pharmacol; 1987 Sep; 24(3):385-9. PubMed ID: 2889461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of famotidine on renal transplant patients treated with ciclosporine A.
    Morel D; Bannwarth B; Vinçon G; Penouil F; Elouaer-Blanc L; Aparicio M; Potaux L
    Fundam Clin Pharmacol; 1993; 7(3-4):167-70. PubMed ID: 8500786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renal function in cyclosporine-treated renal allograft recipients.
    Tanabe K; Novick AC; Streem S; Hodge E
    Urology; 1995 Sep; 46(3):321-7. PubMed ID: 7660506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclosporin level under famotidine administration. Pharmacokinetic study in 20 patients following heart transplantation].
    Schütz A; Kemkes BM
    Fortschr Med; 1990 Aug; 108(23):457-8. PubMed ID: 2210583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclosporine on the rate of renal function recovery after renal transplantation.
    Dumler F
    Henry Ford Hosp Med J; 1989; 37(1):24-7. PubMed ID: 2670841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM; White DJ; Thiru S; Evans DB; Calne RY
    N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
    Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
    Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cyclosporine in pediatric renal transplant recipients.
    Conley SB; Flechner SM; Rose G; Van Buren CT; Brewer E; Kahan BD
    J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
    Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
    N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.